CRIS Current Research Information System

ZAMAGNI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.554
NA - Nord America 2.049
EU - Europa 1.471
AF - Africa 167
SA - Sud America 99
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.010
VN - Vietnam 731
CN - Cina 625
SG - Singapore 623
IT - Italia 563
GB - Regno Unito 169
SE - Svezia 155
HK - Hong Kong 150
DE - Germania 131
KR - Corea 106
IN - India 93
NL - Olanda 90
BR - Brasile 68
FR - Francia 65
CI - Costa d'Avorio 63
BD - Bangladesh 57
RU - Federazione Russa 57
IE - Irlanda 45
FI - Finlandia 41
JP - Giappone 33
BG - Bulgaria 31
CA - Canada 28
TG - Togo 26
PH - Filippine 24
SC - Seychelles 24
UA - Ucraina 23
JO - Giordania 21
CH - Svizzera 20
ZA - Sudafrica 20
AT - Austria 18
ID - Indonesia 18
AR - Argentina 17
PL - Polonia 15
BE - Belgio 14
EE - Estonia 9
TH - Thailandia 9
UZ - Uzbekistan 9
EG - Egitto 8
TR - Turchia 8
TW - Taiwan 8
ES - Italia 7
EC - Ecuador 6
MX - Messico 6
IQ - Iraq 5
NG - Nigeria 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PK - Pakistan 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
NA - Namibia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.346
Salva come PNG Salva come JPEG
Città #
Singapore 451
Ashburn 299
Hefei 206
Ho Chi Minh City 177
Hanoi 152
Fairfield 142
Bologna 141
Hong Kong 139
Chandler 133
Southend 130
San Jose 128
Seoul 99
Santa Clara 75
Houston 68
New York 68
Beijing 66
Wilmington 65
Abidjan 63
Woodbridge 61
Seattle 60
Dallas 54
Los Angeles 52
Ann Arbor 47
Cambridge 46
Boardman 45
Dublin 45
Council Bluffs 43
Princeton 42
Haiphong 36
Helsinki 36
Tokyo 29
Da Nang 28
Milan 28
Sofia 28
Lauterbourg 27
Lomé 26
Frankfurt am Main 24
Hyderabad 24
Dong Ket 23
Amman 21
Florence 21
Bengaluru 19
Rimini 19
Nanjing 18
Turin 18
Berlin 16
Bern 16
Chicago 16
Shanghai 16
Vienna 15
Westminster 15
Amsterdam 14
Buffalo 13
Jakarta 13
Redondo Beach 13
Saint Petersburg 13
Guangzhou 12
Padova 12
São Paulo 12
Atlanta 11
Brussels 11
Jacksonville 11
Rome 11
Warsaw 11
Jinan 10
Redmond 10
Toronto 10
Casalecchio di Reno 9
Cesena 9
Falkenstein 9
Falls Church 9
Hải Dương 9
Munich 9
Tongling 9
London 8
Ninh Bình 8
Nuremberg 8
Brooklyn 7
Charlotte 7
Johannesburg 7
Lugo 7
Orem 7
Phoenix 7
Tashkent 7
Tân Tiến 7
Biên Hòa 6
Boydton 6
Bắc Ninh 6
Changsha 6
Forlì 6
Hebei 6
Montreal 6
Nanchang 6
Nha Trang 6
San Diego 6
Shenyang 6
Verona 6
Abeokuta 5
Bangkok 5
Bến Tre 5
Totale 4.033
Salva come PNG Salva come JPEG
Nome #
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 305
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 302
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 275
Management of malignant cutaneous wounds in oncologic patients 256
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 249
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 245
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 242
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 240
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. 236
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 223
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 209
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 208
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 200
Relevance of ARID1A Mutations in Endometrial Carcinomas 197
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) 181
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control 175
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 173
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 172
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. 168
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival 167
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 166
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 164
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 158
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment 158
null 150
Characterization of BRCA Deficiency in Ovarian Cancer 148
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. 133
Exploring pain management in breast cancer: key findings from the ARISE study 132
Radiotherapy in uterine sarcoma: a narrative review of international guidelines 128
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 115
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System 108
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis 105
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 100
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. 83
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma 83
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 76
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 44
Totale 6.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/2022494 42 23 31 54 43 18 11 30 22 60 99 61
2022/2023579 54 93 30 52 37 41 17 27 112 15 44 57
2023/2024299 31 28 15 14 16 77 11 46 11 12 16 22
2024/20251.135 104 86 112 63 102 56 98 74 28 104 108 200
2025/20263.033 254 396 226 235 252 120 421 91 548 209 160 121
Totale 6.474